Szemészet, 2019 (156. évfolyam, 1-4. szám)

2019-09-01 / 3. szám

A pszeudoexfoliatív szindróma és glaukóma kórélettana Irodalom 1. Konstas AGR Holló G, Ritch R. Exfoliative glaucoma. Schacknow PN, Samples RJ (eds). The glaucoma book. A practical, evidence-based approach to patient care. New York: Springer; 2010. p. 507-516. 2. Konstas AGR Ringvoid A. Epidemiology of exfoliation syndrome. J Glaucoma 2018; 27: S4-S11. 3. Holló G, Kóthy R A pszeudoexfoliációs szindrómához társuló szemészeti és szisztémás elváltozások. Szemészet 2012; 149: 123-132. 4. Holló G. Szisztémás betegségek pszeudoexfoliatív szindrómában. LÁM 2012; 22: 493-498. 5. European Glaucoma Society. Terminology and guidelines for glaucoma. 4th Edition. PubliComm s.r.1., Savona; 2014. 6. Holló G, Katsanos A, Konstas AGP Management of exfoliative glaucoma: challenges and solutions. Clin Ophthalmol 2015; 9: 907-919. 7. Challa R Johnson WM. Composition of exfoliation material. J Glaucoma 2018; 27: S29-S31. 8. Thorleifsson G, Magnusson KR Sulem R Walters GB, Gudbjartsson DE Stefansson H, Jonsson T, Jonasdottir A, Jonasdottir A, Stefansdottir G, Masson G, Hardarson GA, Petursson H, Arnarsson A, Motallebipour M, Wallerman 0, Wadelius C, Gulcher JR, Thorsteinsdottir 0, Kong A, Jonasson E Stefansson K. Common sequence variants in the L0XL1 gene confer suspectibility to exfoliation glaucoma. Science 2007; 317: 1397-1400. 9. Schlötzer-Schrehardt II, Koca MR, Naumann GOH, Volkholz H. Pseudo ­exfoliation syndrome: ocular manifestation of a systemic disorder? Arch Ophthalmol 1992; 110: 1752-1756. 10. Schlötzer-Schrehardt U. Genetics in exfoliation syndrome and exfoliative glaucoma. In. Holló G, Konstas AGP (eds): Exfoliation syndrome and exfoliative glaucoma, 3rd Edition, PubliComm S.r.l., Savona; 2015. p. 57-76. 11. Ye H, Jiang Y, Jing Q, Li D, Maimaiti T, Kasimu D, Lu Y. L0XL1 hypermethy­lation in pseudoexfoliation syndrome in the Uighur population. Invest Ophthalmol Vis Sei 2015; 56: 5838-5843. 12. Berner D, Zenkel M, Pasutto E Hója U, Liravi R Gusek-Schneider GC, Kruse FE, Schödel J, Reis A, Schlötzer-Schrehardt U. Posttranscriptional regulation of L0XL1 expression via alternative splicing and nonsense­­mediated mRNA decay as an adaptive stress response. Invest Ophthalmol Vis Sei 2017; 58: 5930-5940. 13. Garweg JG, Zandi S, Pfister IB, Skowronska M, Gerhardt C. Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfoliation syndrome and glaucoma. PLoS One 2017; 12(8): e0182571. 14. Aboobakar IE Johnson WM, Stamer WD, Hauser MA, Allingham RR. Major review. Exfoliation syndrome; advances in disease genetics, molecular biology, and epidemiology. Exp Eye Res 2017; 154: 88-103. 15. Koliakos GG, Konstas AGR Holló G. Biochemistry and genetics of exfoliation syndrome. In. Holló G, Konstas AGP (eds.). Exfoliation syndrome and exfoliative glaucoma, 3rd Edition, PubliComm S.r.l, Savona; 2015. p. 45-56. 16. Tanito M, Kaidzu S, Takai Y, Ohira A. Status of systemic oxidative stresses in patients with primary open-angle glaucoma and pseudoexfoliation syndrome. PLoS One 2012; 7(11): e49680. 17. Yagci R, Ersöz I, Erdurmug M, Gürel A, Dumán S. Protein carbonyl levels in the aqueous humour and serum of patients with pseudoexfoliation syndrome. Eye 2008; 22: 128-131. 18. Koliakos GG, Konstas AG, Schlötzer-Schrehardt U, Bufidis T, Georgiadis N, Ringvoid A. Ascorbic acid concentration is reduced in the aqueous humor of patients with exfoliation syndrome. Am J Ophthalmol 2002; 134: 879-883. 19. Schlötzer-Schrehardt U, Lommatzsch J, Küchle M, Konstas AG, Naumann GO. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/ glaucoma and primary open­angle glaucoma. Invest Ophthalmol Vis Sei 2003; 44: 1117-1125. 20. Schlötzer-Schrehardt U, Zenkel M, Küchle M, Sakai LY, Naumann GOH. Role of transforming growth factor-betal and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res 2001; 73: 765-780. 21. Koliakos GG, Konstas AG, Schlötzer-Schrehardt U, Holló G, Katsimbris IE, Georgiadis N, Ritch R. 8-lsoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 2003; 87: 353-356. 22. Koliakos GG, Konstas AG, Schlötzer-Schrehardt U, Holló G, Mitova D, Kovatchev D, Maloutas S, Georgiadis N. Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 2004; 88: 523-527. 23. Pasquale LR. Environmental factors in relation to exfoliation syndrome and exfoliative glaucoma. In: Holló G, Konstas AGP (eds.). Exfoliation syndrome and exfoliative glaucoma, 3rd Edition, PubliComm S.nl., Savona; 2015. p. 96-105. 24. Wolosin JM, Ritch R, Bernstein AM. Is Autophagy dysfunction a key to exfoliation glaucoma? J Glaucoma 2018; 27: 197-201. 25. Fan BJ, Pasquale LR, Kang JH, Levkovitch-Verbin H, Haines JL, Wiggs JL. Association of clusterin (CLU) variants and exfoliation syndrome: An analysis in two Caucasian studies and a meta-analysis. Exp Eye Res 2015; 139: 115-122. 26. Doudevski I, Rostagno A, Cowman M, Liebmann J, Ritch R, Ghiso J. Clusterin and complement activation in exfoliation glaucoma. Invest Ophthalmol Vis Sei 2014; 55: 2491-2499. 27. Vazquez-Ferreiro R Carrera-Hueso FJ, Fikri-Benbrahim N, Barreiro- Rodriguez L, Diaz-Rey M, Ramón Barrios MA. Intraocular lens dislocation in pseudoexfoliation: a systematic review and meta-analysis. Acta Ophthalmol 2017; 95: e164-e169. 28. Schlötzer-Schrehardt U, Hammer CM, Krysta AW, Hofmann-Rummelt C, Pasutto E Sasaki T, Kruse FE, Zenkel M. L0XL1 deficiency in the lamina cribrosa as candidate susceptibility factor for a pseudoexfoliation-specific risk of glaucoma. Ophthalmology 2012; 119: 1832-1843. 29. Moghimi S, Nekoozadeh S, Motamed-Gorji N, Chen R, Fard MA, Mohammadi M, Weinreb RN. Lamina cribrosa and choroid features and their relationship to stage of pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sei 2018; 59: 5355-5365. 30. Kim S, Sung KR, Lee JR, Lee KS. Evaluation of lamina cribrosa in pseudoexfoliation syndrome using spectral-domain optical coherence tomography enhanced depth imaging. Ophthalmology 2010; 120: 1798-803. 31. Heijl A, Bengtsson B, Hyman L, Leske MC, Early Manifest Glaucoma Trial Group. Natural history of open-angle glaucoma. Ophthalmology 2009; 116:2271-2276. 32. Konstas AG, Holló G, Astakhov YS, Teus MA, Akopov EL, Jenkins JN, Stewart WO. Factors associated with long-term progression or stability in exfoliation glaucoma. Arch Ophthalmol 2004; 122: 29-33. 33. Holló G, Lakatos R Farkas K. Cold pressor test and plasma endothelin-1 concentration in primary open-angle and capsular glaucoma. J Glaucoma 1998; 7: 105-110. 34. Visontai Zs, Merisch B, Kollai M, Holló G. Increase of carotid artery stiffness and decrease of baroreflex sensitivity in exfoliation syndrome and glaucoma. Br J Ophthalmol 2006; 90: 563-567. 35. Visontai Z, Horváth T, Kollai M, Holló G. Decreased cardiovagal regulation in exfoliation syndrome. J Glaucoma 2008; 17: 133-138. 36. Schumacher S, Schlötzer-Schrehardt U, Martus R Lang W, Naumann GO. Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet 2001; 357: 359-360. 37. Wirostko BM, Curtin K, Ritch R, Thomas S, Allen-Brady K, Smith KR, Hageman GS, Allingham RR. Risk for exfoliation syndrome in women with pelvic organ prolapse: a Utah Project on Exfoliation Syndrome (UPEXS) Study. JAMA Ophthalmol 2016; 134: 1255-1262. 38. Besch BM, Curtin K, Ritch R, Allingham RR, Wirostko BM. Association of exfoliation syndrome with risk of indirect inguinal hernia: the Utah Project on Exfoliation Syndrome. JAMA Ophthalmol 2018; 136: 1368-1374. 39. Holló G. Vascular dysfunction in exfoliation syndrome. J Glaucoma 2018; 27: S-72-S74. 40. Konstas AGR Holló G, Astakhov YS, Teus MA, Akopov EL, Jenkins JN, Stewart WC. Presentation and long-term follow-up of exfoliation glaucoma in Greece, Spain, Russia and Hungary. Eur J Ophthalmol 2006; 16: 60-66. 41. Anastasopoulos E, Coleman AL, Wilson MR, Sinsheimer JS, Yu F, Katafigiotis S, Founti R Salonikiou A, Pappas T, Koskosas A, Katopodi T, Lambropoulos A, Topouzis E Association of L0XL1 polymorphisms with pseudoexfoliation, glaucoma, intraocular pressure, and systemic diseases in a Greek population. The Thessaloniki Eye Study. Invest Ophthalmol Vis Sei 2014; 55: 4238-4243. Levelezési cím Dr. Holló Gábor, Semmelweis Egyetem, Szemészeti Klinika 1085 Budapest, Mária u. 39. E-mail: hollo.gabor@med.semmelweis-univ.hu Í123';

Next

/
Oldalképek
Tartalom